Clinical Trial

Azithromycin for Critical Asthma - Pediatrics

Study acronym: CR-AZI Kids
Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-07-31 -> 2026-12-31 2026-08-12
minor Completion pushed: 2026-12-31 -> 2027-06-30 2026-08-12
Trial Details
NCT Number NCT06223828
Lead Sponsor Johns Hopkins All Children's Hospital
Conditions Pediatric Asthma, Critical Illness
Enrollment 100 participants
Start Date 2024-04-02
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-11